Wanbury has successfully completed the Brazilian Health Authority (ANVISA) audit at its Tanuku plant facility in Andhra Pradesh in the month of December 2024 without any observations. This will enable the company to maintain and further solidify its position in this important market.
The facility has been upgraded to meet all global regulatory requirements and should meet the highest level of compliance standards. With the completion of upgradation, the company has started full-fledged manufacturing operations and the plant will now be running at optimum capacity to meet customer demand.
Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.
